TY - JOUR
T1 - Trastorno por uso de cocaína y depresión
T2 - Cuando el diagnóstico clínico no es suficiente
AU - Alías-Ferri, María
AU - García-Marchena, Nuria
AU - Mestre-Pintó, Joan Ignasi
AU - Araos, Pedro
AU - Vergara-Moragues, Esperanza
AU - Fonseca, Francina
AU - González-Saiz, Francisco
AU - de Fonseca, Fernando Rodríguez
AU - Torrens, Marta
AU - Mateus, J.
AU - Papaseit, E.
AU - Pérez-Mañá, C.
AU - Rodríguez-Minguela, R.
AU - Rossi, P.
AU - Tamarit, C.
AU - Vallecillo, G.
N1 - Funding Information:
This work was supported by: Instituto de Salud Carlos III–FEDER-Red de Trastornos Adictivos UE-FEDER 2016 (RD16/0017/0010 and RD16/0017/0001); FONDO DE INVESTIGACIÓN SANITARIA. ISCIII (PI14/00178); Research project funded by Ministerio de Sanidad, Servi-cios Sociales e Igualdad and Plan Nacional sobre Drogas (PNSD-2018I044); Research project funded by Ministerio de Sanidad, Servicios Sociales e Igualdad and Plan Nacio-nal sobre Drogas (043/2017); Research project funded by Consejería de Economía, Innovación y Ciencia, Junta de Andalucía and ERDF-EU (CTS-433); Research projects funded by Consejería de Salud y Bienestar Social, Junta de Andalucía-Fundación Progreso y Salud (EF-0202-2017 and PI-0140-2018) and Research Project funded by Uni-versidad de Málaga-Incorporación a Doctores, Plan Propio (CI-17-415); Acció instrumental d’Intensificació de Professionals de la Salut - Facultatius especialistes (PERIS: SLT006/17/00014); Plan Nacional de Drogas de España (PND no. 2007i078); AGAUR-Suport Grups de Recerca (2017 SGR530).
Funding Information:
This work was supported by: Instituto de Salud Carlos III–FEDER-Red de Trastornos Adictivos UE-FEDER 2016 (RD16/0017/0010 and RD16/0017/0001); FONDO DE INVESTIGACIÓN SANITARIA. ISCIII (PI14/00178); Research project funded by Ministerio de Sanidad, Servicios Sociales e Igualdad and Plan Nacional sobre Drogas (PNSD-2018I044); Research project funded by Ministerio de Sanidad, Servicios Sociales e Igualdad and Plan Nacional sobre Drogas (043/2017); Research project funded by Consejería de Economía, Innovación y Ciencia, Junta de Andalucía and ERDF-EU (CTS-433); Research projects funded by Consejería de Salud y Bienestar Social, Junta de Andalucía-Fundación Progreso y Salud (EF-0202-2017 and PI-0140-2018) and Research Project funded by Universidad de Málaga-Incorporación a Doctores, Plan Propio (CI-17-415); Acció instrumental d’Intensificació de Professionals de la Salut - Facultatius especialistes (PERIS: SLT006/17/00014); Plan Nacional de Drogas de España (PND no. 2007i078); AGAUR-Suport Grups de Recerca (2017 SGR530).
Publisher Copyright:
© 2021, Edita Socidrogalcohol. All rights reserved.
PY - 2021
Y1 - 2021
N2 - Background: Cocaine use is a growing global health problem and patients with cocaine use disorders (CUD) present several complications, including high rates of major depression. There are two types of major depressive disorder (MDD) in these subjects: Primary major depressive disorder (P-MDD) and cocaine-induced major depressive disorder (CI-MDD). To improve treatment, it is necessary to distinguish between both types. The aim of this study was to assess the differences in depressive symptomatology criteria (P-MDD vs CI-MDD) in CUD patients. Methods: Secondary data analysis was carried out with a cross-sectional sample of 160 patients presenting CUD and MDD. Clinical assessment was performed using the Psychiatric Research Interview for Substance and Mental Disorders (PRISM). A differential diagnosis was obtained between P-MDD and CI-MDD. Results: Men represented 80% of the sample, the mean age was 38.61 years, and 64.5% had elementary studies. CI-MDD diagnosis (61.3%) was more frequent than P-MDD (38.7%). There was a younger age of CUD onset in CI-MDD patients. In addition, 79.4% of the patients had another substance use disorder diagnosed. The criterion “Changes in weight or appetite” was more prevalent (57.1%) in P-MDD group. Conclusions: We found differences in the criterion “Changes in weight or appetite”. Further research is needed in this field in order to establish a differential diagnosis and thus provide better treatment for CUD individuals.
AB - Background: Cocaine use is a growing global health problem and patients with cocaine use disorders (CUD) present several complications, including high rates of major depression. There are two types of major depressive disorder (MDD) in these subjects: Primary major depressive disorder (P-MDD) and cocaine-induced major depressive disorder (CI-MDD). To improve treatment, it is necessary to distinguish between both types. The aim of this study was to assess the differences in depressive symptomatology criteria (P-MDD vs CI-MDD) in CUD patients. Methods: Secondary data analysis was carried out with a cross-sectional sample of 160 patients presenting CUD and MDD. Clinical assessment was performed using the Psychiatric Research Interview for Substance and Mental Disorders (PRISM). A differential diagnosis was obtained between P-MDD and CI-MDD. Results: Men represented 80% of the sample, the mean age was 38.61 years, and 64.5% had elementary studies. CI-MDD diagnosis (61.3%) was more frequent than P-MDD (38.7%). There was a younger age of CUD onset in CI-MDD patients. In addition, 79.4% of the patients had another substance use disorder diagnosed. The criterion “Changes in weight or appetite” was more prevalent (57.1%) in P-MDD group. Conclusions: We found differences in the criterion “Changes in weight or appetite”. Further research is needed in this field in order to establish a differential diagnosis and thus provide better treatment for CUD individuals.
KW - Cocaine use disorder
KW - Cocaine-related disorders
KW - Depressive disorder
KW - Dual diagnosis
KW - Induced depression
UR - http://www.scopus.com/inward/record.url?scp=85111953425&partnerID=8YFLogxK
U2 - 10.20882/adicciones.1321
DO - 10.20882/adicciones.1321
M3 - Artículo
C2 - 32100040
AN - SCOPUS:85111953425
SN - 0214-4840
VL - 33
SP - 193
EP - 200
JO - Adicciones
JF - Adicciones
IS - 3
ER -